ConductScience.org, home

Paper36677483

Omicron Sub-Lineage BA.5 and Recombinant XBB Evasion from Antibody Neutralisation in BNT162b2 Vaccine Recipients.

Brandolini M and 13 others. Microorganisms, 2023. Cited by 10 papers, by iCite.

Cite this record

ConductScience Library. Omicron Sub-Lineage BA.5 and Recombinant XBB Evasion from Antibody Neutralisation in BNT162b2 Vaccine Recipients. Papers, record 36677483. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36677483

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Omicron Sub-Lineage BA.5 and Recombinant XBB Evasion from Antibody Neutralisation in BNT162b2 Vaccine Recipients.
PubMed
Journal
Microorganisms
PubMed
Year
2023
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
10
iCite
Relative citation ratio, by iCite
0.6
iCite
Revised in PubMed
2023-02-01
PubMed

Authors14

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Brandolini MMartina
2Gatti GGiulia
3Grumiro LLaurahttps://orcid.org/0000-0003-2297-3009
4Zannoli SSilvia
5Arfilli VValentina
6Cricca MMonica
7Dirani GGiorgio
8Denicolò AAgnese
9Marino MMMaria Michela
10Manera MMartina
11Mancini AAndrea
12Taddei FFrancescahttps://orcid.org/0000-0003-2707-2082
13Semprini SSimona
14Sambri VVittoriohttps://orcid.org/0000-0002-5012-7355

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References21

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
135752633Detection of SARS-CoV-2 intra-host recombination during superinfection with Alpha and Epsilon variants in New York City.Nat Commun2022https://conductscience.org/library/papers/35752633PubMed
219016439Growth and maintenance of Vero cell lines.Curr Protoc Microbiol2008https://conductscience.org/library/papers/19016439PubMed
335450114Mutational Pattern, Impacts and Potential Preventive Strategies of Omicron SARS-CoV-2 Variant Infection.Infect Drug Resist2022https://conductscience.org/library/papers/35450114PubMed
433619260SARS-CoV-2 vaccines strategies: a comprehensive review of phase 3 candidates.NPJ Vaccines2021https://conductscience.org/library/papers/33619260PubMed
536109713SARS-CoV-2 infection, vaccination, and antibody response trajectories in adults: a cohort study in Catalonia.BMC Med2022https://conductscience.org/library/papers/36109713PubMed
634035118SARS-CoV-2 variants of concern partially escape humoral but not T-cell responses in COVID-19 convalescent donors and vaccinees.Sci Immunol2021https://conductscience.org/library/papers/34035118PubMed
735419806The recombinant variants of SARS-CoV-2: Concerns continues amid COVID-19 pandemic.J Med Virol2022https://conductscience.org/library/papers/35419806PubMed
835271316COVID-19 vaccination: The road ahead.Science2022https://conductscience.org/library/papers/35271316PubMed
935597776Heterogeneous SARS-CoV-2 humoral response after COVID-19 vaccination and/or infection in the general population.Sci Rep2022https://conductscience.org/library/papers/35597776PubMed
1035746710Recombination in Coronaviruses, with a Focus on SARS-CoV-2.Viruses2022https://conductscience.org/library/papers/35746710PubMed
1133684923Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7.Nature2021https://conductscience.org/library/papers/33684923PubMed
1234192737Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2.Nature2021https://conductscience.org/library/papers/34192737PubMed
1332585083An In Vitro Microneutralization Assay for SARS-CoV-2 Serology and Drug Screening.Curr Protoc Microbiol2020https://conductscience.org/library/papers/32585083PubMed
1435130825A comprehensive review of SARS-CoV-2 vaccines: Pfizer, Moderna & Johnson & Johnson.Hum Vaccin Immunother2022https://conductscience.org/library/papers/35130825PubMed
1533479399COVID-19 vaccines: where we stand and challenges ahead.Cell Death Differ2021https://conductscience.org/library/papers/33479399PubMed
1617868000IFCC position paper: report of the IFCC taskforce on ethics: introduction and framework.Clin Chem Lab Med2007https://conductscience.org/library/papers/17868000PubMed
1735864211Mutational induction in SARS-CoV-2 major lineages by experimental exposure to neutralising sera.Sci Rep2022https://conductscience.org/library/papers/35864211PubMed
1832458296On the Calculation of TCID50 for Quantitation of Virus Infectivity.Virol Sin2021https://conductscience.org/library/papers/32458296PubMed
1934647020Heterogeneous Longitudinal Antibody Responses to Covid-19 mRNA Vaccination.Clin Pathol2021https://conductscience.org/library/papers/34647020PubMed
2033536258Recurrent deletions in the SARS-CoV-2 spike glycoprotein drive antibody escape.Science2021https://conductscience.org/library/papers/33536258PubMed

See all 21 referencesDownload CSV of references

Cited by8

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 10 citations.

PMIDTitleJournalYearIn PapersSource
41299695The virology of Omicron: pathophysiology, immune regulation, and clinical impact of SARS-CoV-2 sub variants.Virol J2025https://conductscience.org/library/papers/41299695PubMed
41234640SARS-CoV-2 mRNA vaccine candidate encoding RBD chimera of Delta and Omicron variants: immunogenic potential and validation.Iran J Microbiol2025https://conductscience.org/library/papers/41234640PubMed
41011531Neutralizing Antibodies vs. Viruses: Interacting Mechanisms and Escape Tactics.Microorganisms2025https://conductscience.org/library/papers/41011531PubMed
40145092The XBB.1.5 mRNA booster vaccine does not significantly increase the percentage of XBB.1.5 mono-reactive T cells.Front Immunol2025https://conductscience.org/library/papers/40145092PubMed
39499071Effect of wild-type vaccine doses on BA.5 hybrid immunity, disease severity, and XBB reinfection risk.J Virol2024https://conductscience.org/library/papers/39499071PubMed
39323472Structural and genomic evolutionary dynamics of Omicron variant of SARS-CoV-2 circulating in Madhya Pradesh, India.Front Med (Lausanne)2024https://conductscience.org/library/papers/39323472PubMed
39179492Worldwide SARS-CoV-2 Omicron variant infection: Emerging sub-variants and future vaccination perspectives.J Formos Med Assoc2025https://conductscience.org/library/papers/39179492PubMed
37560529The effects of amino acid substitution of spike protein and genomic recombination on the evolution of SARS-CoV-2.Front Microbiol2023https://conductscience.org/library/papers/37560529PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36677483

GET https://conductscience.org/api/papers/v1/36677483/references?page=2